ClinicalTrials.govpublic full text
Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)
rheumatoid arthritis, joint disease, arthritis, certolizumab pegol, cimzia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803450
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.